메뉴 건너뛰기




Volumn 12, Issue 2, 2011, Pages 88-95

Effects of cilostazol in the heart

Author keywords

arrhythmia; Brugada syndrome; cilostazol; heart; ventricular fibrillation

Indexed keywords

CILOSTAZOL; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; PIPERANOMETOZINE; THEOPHYLLINE;

EID: 79953647359     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283439746     Document Type: Review
Times cited : (57)

References (78)
  • 2
    • 0032544181 scopus 로고    scopus 로고
    • Cilostazol has beneficial effects in treatment of intermittent claudication: Results from a multicenter, randomized, prospective, double- Blind trial
    • Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 1998; 98:678-686. (Pubitemid 28387495)
    • (1998) Circulation , vol.98 , Issue.7 , pp. 678-686
    • Dawson, D.L.1    Cutler, B.S.2    Meissner, M.H.3    Strandness Jr., D.E.4
  • 3
    • 0035963659 scopus 로고    scopus 로고
    • Analysis of the cilostazol safety database
    • Pratt CM. Analysis of the cilostazol safety database. Am J Cardiol 2001; 87:28D-33D.
    • (2001) Am J Cardiol , vol.87
    • Pratt, C.M.1
  • 4
    • 0031966371 scopus 로고    scopus 로고
    • Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias
    • DOI 10.1097/00005344-199804000-00010
    • Atarashi H, Endoh Y, Saitoh H, Kishida H, Hayakawa H. Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias. J Cardiovasc Pharmacol 1998; 31:534-539. (Pubitemid 28153129)
    • (1998) Journal of Cardiovascular Pharmacology , vol.31 , Issue.4 , pp. 534-539
    • Atarashi, H.1    Endoh, Y.2    Saitoh, H.3    Kishida, H.4    Hayakawa, H.5
  • 5
    • 77953809302 scopus 로고    scopus 로고
    • The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: Principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study - A randomized trial
    • Katakami N, Kim YS, Kawamori R, Yamasaki Y. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study - a randomized trial. Circulation 2010; 121:2584-2591.
    • (2010) Circulation , vol.121 , pp. 2584-2591
    • Katakami, N.1    Kim, Y.S.2    Kawamori, R.3    Yamasaki, Y.4
  • 6
    • 0037389193 scopus 로고    scopus 로고
    • Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block
    • DOI 10.1378/chest.123.4.1161
    • Kodama-Takahashi K, Kurata A, Ohshima K, Yamamoto K, Uemura S, Watanabe S, et al. Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block. Chest 2003; 123:1161-1169. (Pubitemid 36444374)
    • (2003) Chest , vol.123 , Issue.4 , pp. 1161-1169
    • Kodama-Takahashi, K.1    Kurata, A.2    Ohshima, K.3    Yamamoto, K.4    Uemura, S.5    Watanabe, S.6    Iwata, T.7
  • 7
    • 0037388986 scopus 로고    scopus 로고
    • Cilostazol: An 'intermittent claudication' remedy for the management of third-degree AV block
    • Madias JE. Cilostazol: an 'intermittent claudication' remedy for the management of third-degree AV block. Chest 2003; 123:979-982.
    • (2003) Chest , vol.123 , pp. 979-982
    • Madias, J.E.1
  • 10
    • 0035122176 scopus 로고    scopus 로고
    • Effects of cilostazol in patients with bradycardiac atrial fibrillation
    • Kishida M, Watanabe K, Tsuruoka T. Effects of cilostazol in patients with bradycardiac atrial fibrillation. J Cardiol 2001; 37:27-33. (Pubitemid 32148163)
    • (2001) Journal of Cardiology , vol.37 , Issue.1 , pp. 27-33
    • Kishida, M.1    Watanabe, K.2    Tsuruoka, T.3
  • 12
    • 0035996742 scopus 로고    scopus 로고
    • Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome
    • Tsuchiya T, Ashikaga K, Honda T, Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002; 13:698-701. (Pubitemid 34774909)
    • (2002) Journal of Cardiovascular Electrophysiology , vol.13 , Issue.7 , pp. 698-701
    • Tsuchiya, T.1    Ashikaga, K.2    Honda, T.3    Arita, M.4
  • 14
    • 0026072848 scopus 로고
    • Effect of oral milrinone on mortality in severe chronic heart failure
    • The PROMISE Study Research Group
    • Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, Di Bianco R, Zeldis SM, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325:1468-1475.
    • (1991) N Engl J Med , vol.325 , pp. 1468-1475
    • Packer, M.1    Carver, J.R.2    Rodeheffer, R.J.3    Ivanhoe, R.J.4    Di Bianco, R.5    Zeldis, S.M.6
  • 15
    • 38649119141 scopus 로고    scopus 로고
    • Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A study in long-term effects)
    • Hiatt WR, Money SR, Brass EP. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: a study in long-term effects). J Vasc Surg 2008; 47:330-336.
    • (2008) J Vasc Surg , vol.47 , pp. 330-336
    • Hiatt, W.R.1    Money, S.R.2    Brass, E.P.3
  • 17
    • 0035544829 scopus 로고    scopus 로고
    • Cilostazol (Pletal): A dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake
    • Liu Y, Shakur Y, Yoshitake M, Kambayashi JJ. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovasc Drug Rev 2001; 19:369-386. (Pubitemid 34260705)
    • (2001) Cardiovascular Drug Reviews , vol.19 , Issue.4 , pp. 369-386
    • Liu, Y.1    Shakur, Y.2    Yoshitake, M.3    Kambayashi, J.-I.4
  • 19
    • 0034770840 scopus 로고    scopus 로고
    • Interplay between inhibition of adenosine uptake and phosphodiesterase type 3 on cardiac function by cilostazol, an agent to treat intermittent claudication
    • DOI 10.1097/00005344-200111000-00014
    • Wang S, Cone J, Fong M, Yoshitake M, Kambayashi J, Liu Y. Interplay between inhibition of adenosine uptake and phosphodiesterase type 3 on cardiac function by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol 2001; 38:775-783. (Pubitemid 32983284)
    • (2001) Journal of Cardiovascular Pharmacology , vol.38 , Issue.5 , pp. 775-783
    • Wang, S.1    Cone, J.2    Fong, M.3    Yoshitake, M.4    Kambayashi, J.-I.5    Liu, Y.6
  • 22
    • 20144384243 scopus 로고    scopus 로고
    • Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F
    • Kim MJ, Park KG, Lee KM, Kim HS, Kim SY, Kim CS, et al. Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F. Hypertension 2005; 45:552-556.
    • (2005) Hypertension , vol.45 , pp. 552-556
    • Kim, M.J.1    Park, K.G.2    Lee, K.M.3    Kim, H.S.4    Kim, S.Y.5    Kim, C.S.6
  • 25
    • 33748446380 scopus 로고    scopus 로고
    • Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death
    • DOI 10.1016/j.ijcard.2005.11.106, PII S0167527306001525
    • Phrommintikul A, Chattipakorn N. Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death. Int J Cardiol 2006; 112:142-152. (Pubitemid 44353799)
    • (2006) International Journal of Cardiology , vol.112 , Issue.2 , pp. 142-152
    • Phrommintikul, A.1    Chattipakorn, N.2
  • 26
    • 0020605971 scopus 로고
    • Evaluation of a new bipyridine inotropic agent - Milrinone - in patients with severe congestive heart failure
    • Baim DS, McDowell AV, Cherniles J, Monrad ES, Parker JA, Edelson J, et al. Evaluation of a new bipyridine inotropic agent - milrinone - in patients with severe congestive heart failure. N Engl J Med 1983; 309:748-756. (Pubitemid 13004282)
    • (1983) New England Journal of Medicine , vol.309 , Issue.13 , pp. 748-756
    • Baim, D.S.1    McDowell, A.V.2    Cherniles, J.3
  • 27
    • 0018246273 scopus 로고
    • Hemodynamic assessment of amrinone. A new inotropic agent
    • Benotti JR, Grossman W, Braunwald E, Davolos DD, Alousi AA. Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med 1978; 299:1373-1377. (Pubitemid 9092478)
    • (1978) New England Journal of Medicine , vol.299 , Issue.25 , pp. 1373-1377
    • Benotti, J.R.1    Grossman, W.2    Braunwald, E.3
  • 28
    • 0022001187 scopus 로고
    • Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside
    • Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J Clin Invest 1985; 75:643-649. (Pubitemid 15142075)
    • (1985) Journal of Clinical Investigation , vol.75 , Issue.2 , pp. 643-649
    • Jaski, B.E.1    Fifer, M.A.2    Wright, R.F.3
  • 29
    • 0023257748 scopus 로고
    • Acute hemodynamic and hormonal effects of CI-930, a new phosphodiesterase inhibitor, in severe congestive heart failure
    • DOI 10.1016/0002-9149(87)90919-2
    • Murali S, Uretsky BF, Valdes AM, Kolesar JA, Reddy PS. Acute hemodynamic and hormonal effects of CI-930, a new phosphodiesterase inhibitor, in severe congestive heart failure. Am J Cardiol 1987; 59:1356-1360. (Pubitemid 17093820)
    • (1987) American Journal of Cardiology , vol.59 , Issue.15 , pp. 1356-1360
    • Murali, S.1    Uretsky, B.F.2    Valdes, A.M.3
  • 30
    • 0025811327 scopus 로고
    • Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure
    • Rauch B, Zimmermann R, Kapp M, Haass M, VonMolitor S, Smolarz A, et al. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure. Clin Cardiol 1991; 14:386-395.
    • (1991) Clin Cardiol , vol.14 , pp. 386-395
    • Rauch, B.1    Zimmermann, R.2    Kapp, M.3    Haass, M.4    VonMolitor, S.5    Smolarz, A.6
  • 31
    • 0020533858 scopus 로고
    • Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying disease
    • Sinoway LS, Maskin CS, Chadwick B, Forman R, Sonnenblick EH, Le Jemtel TH. Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease. J Am Coll Cardiol 1983; 2:327-331. (Pubitemid 13078799)
    • (1983) Journal of the American College of Cardiology , vol.2 , Issue.2 , pp. 327-331
    • Sinoway, L.S.1    Maskin, C.S.2    Chadwick, B.3
  • 33
    • 0024537314 scopus 로고
    • Electrophysiology of phosphodiesterase inhibitors
    • Naccarelli GV, Goldstein RA. Electrophysiology of phosphodiesterase inhibitors. Am J Cardiol 1989; 63:35A-40A.
    • (1989) Am J Cardiol , vol.63
    • Naccarelli, G.V.1    Goldstein, R.A.2
  • 34
    • 0346334593 scopus 로고    scopus 로고
    • PDE3 Inhibition in Dilated Cardiomyopathy: Reasons to Reconsider
    • DOI 10.1016/S1071-9164(03)00135-0
    • Movsesian MA. PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider. J Card Fail 2003; 9:475-480. (Pubitemid 38055657)
    • (2003) Journal of Cardiac Failure , vol.9 , Issue.6 , pp. 475-480
    • Movsesian, M.A.1
  • 35
    • 0032698819 scopus 로고    scopus 로고
    • Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: Shifting the focus from inotropy to cyclic adenosine monophosphate
    • Movsesian MA. Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate. J Am Coll Cardiol 1999; 34:318-324.
    • (1999) J Am Coll Cardiol , vol.34 , pp. 318-324
    • Movsesian, M.A.1
  • 36
    • 0034949792 scopus 로고    scopus 로고
    • Combined phosphodiesterase inhibition and beta-blockade in the GII04313, decreases ischemia-induced arrhythmias in the rat
    • Carceles MD, Aleixandre F, Fuente T, Lopez-Vidal J, Laorden ML. Combined phosphodiesterase inhibition and beta-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat. Can J Anaesth 2001; 48:486-492. (Pubitemid 32591254)
    • (2001) Canadian Journal of Anesthesia , vol.48 , Issue.5 , pp. 486-492
    • Carceles, M.D.1    Aleixandre, F.2    Fuente, T.3    Lopez-Vidal, J.4    Laorden, M.L.5
  • 37
    • 0036233984 scopus 로고    scopus 로고
    • Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure
    • Hauptman PJ, Woods D, Prirzker MR. Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure. Clin Cardiol 2002; 25:247-249. (Pubitemid 34457370)
    • (2002) Clinical Cardiology , vol.25 , Issue.5 , pp. 247-249
    • Hauptman, P.J.1    Woods, D.2    Pritzker, M.R.3
  • 38
    • 0034878176 scopus 로고    scopus 로고
    • Carvedilol titration in patients with congestive heart failure receiving inotropic therapy
    • DOI 10.1067/mhj.2001.117605
    • Kumar A, Choudhary G, Antonio C, Just V, Jain A, Heaney L, et al. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy. Am Heart J 2001; 142:512-515. (Pubitemid 32801637)
    • (2001) American Heart Journal , vol.142 , Issue.3 , pp. 512-515
    • Kumar, A.1    Choudhary, G.2    Antonio, C.3    Just, V.4    Jain, A.5    Heaney, L.6    Papp, M.A.7
  • 40
    • 28244461264 scopus 로고    scopus 로고
    • Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium
    • DOI 10.1074/jbc.M506760200
    • Hambleton R, Krall J, Tikishvili E, Honeggar M, Ahmad F, Manganiello VC, et al. Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium. J Biol Chem 2005; 280:39168-39174. (Pubitemid 41713868)
    • (2005) Journal of Biological Chemistry , vol.280 , Issue.47 , pp. 39168-39174
    • Hambleton, R.1    Krall, J.2    Tikishvili, E.3    Honeggar, M.4    Ahmad, F.5    Manganiello, V.C.6    Movsesian, M.A.7
  • 42
    • 0032865827 scopus 로고    scopus 로고
    • Human heart failure: CAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban
    • Schmidt U, Hajjar RJ, Kim CS, Lebeche D, Doye AA, Gwathmey JK. Human heart failure: cAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban. Am J Physiol 1999; 277:H474-H480.
    • (1999) Am J Physiol , vol.277
    • Schmidt, U.1    Hajjar, R.J.2    Kim, C.S.3    Lebeche, D.4    Doye, A.A.5    Gwathmey, J.K.6
  • 43
    • 24644524532 scopus 로고    scopus 로고
    • Mechanism of sudden cardiac death
    • Rubart M, Zipes DP. Mechanism of sudden cardiac death. J Clin Invest 2005; 115:2305-2315.
    • (2005) J Clin Invest , vol.115 , pp. 2305-2315
    • Rubart, M.1    Zipes, D.P.2
  • 44
    • 0025020589 scopus 로고
    • Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure
    • Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990; 81:III21-III32.
    • (1990) Circulation , vol.81
    • Morgan, J.P.1    Erny, R.E.2    Allen, P.D.3    Grossman, W.4    Gwathmey, J.K.5
  • 45
    • 0034237310 scopus 로고    scopus 로고
    • Myocardial efficiency in stunned myocardium. Comparison of Ca(2+)-sensitization and PDE III-inhibition on energy consumption
    • Sunderdiek U, Korbmacher B, Gams E, Schipke JD. Myocardial efficiency in stunned myocardium. Comparison of Ca(2+)-sensitization and PDE III-inhibition on energy consumption. Eur J Cardiothorac Surg 2000; 18:83-89.
    • (2000) Eur J Cardiothorac Surg , vol.18 , pp. 83-89
    • Sunderdiek, U.1    Korbmacher, B.2    Gams, E.3    Schipke, J.D.4
  • 46
    • 0035984729 scopus 로고    scopus 로고
    • Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease
    • Feldman AM, McNamara DM. Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease. Clin Cardiol 2002; 25:256-262. (Pubitemid 34568582)
    • (2002) Clinical Cardiology , vol.25 , Issue.6 , pp. 256-262
    • Feldman, A.M.1    McNamara, D.M.2
  • 47
    • 0022481941 scopus 로고
    • Electrophysiologic effects of milrinone in patients with congestive heart failure
    • DOI 10.1016/0002-9149(86)90847-7
    • Goldstein RA, Geraci SA, Gray EL, Rinkenberger RL, Dougherty AH, Naccarelli GV. Electrophysiologic effects of milrinone in patients with congestive heart failure. Am J Cardiol 1986; 57:624-628. (Pubitemid 16015950)
    • (1986) American Journal of Cardiology , vol.57 , Issue.8 , pp. 624-628
    • Goldstein, R.A.1    Geraci, S.A.2    Gray, E.L.3
  • 48
    • 8844274873 scopus 로고    scopus 로고
    • Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD
    • DOI 10.1016/j.ejheart.2004.10.003, PII S1388984204002806
    • Lalukota K, Cleland JG, Ingle L, Clark AL, Coletta AP. Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD. Eur J Heart Fail 2004; 6:953-955. (Pubitemid 39536312)
    • (2004) European Journal of Heart Failure , vol.6 , Issue.7 , pp. 953-955
    • Lalukota, K.1    Cleland, J.G.F.2    Ingle, L.3    Clark, A.L.4    Coletta, A.P.5
  • 51
    • 0014000319 scopus 로고
    • The chronotropic effect of adenine- and hypoxanthine derivatives on isolated rat hearts before and after removing the sino-auricular node
    • Versprille A. The chronotropic effect of adenine- and hypoxanthine derivatives on isolated rat hearts before and after removing the sino-auricular node. Pflugers Arch Gesamte Physiol Menschen Tiere 1966; 291:261-267.
    • (1966) Pflugers Arch Gesamte Physiol Menschen Tiere , vol.291 , pp. 261-267
    • Versprille, A.1
  • 52
    • 0020619188 scopus 로고
    • Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heart
    • Lubbe WF, Nguyen T, West EJ. Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heart. Fed Proc 1983; 42:2460-2464. (Pubitemid 13043668)
    • (1983) Federation Proceedings , vol.42 , Issue.8 , pp. 2460-2464
    • Lubbe, W.F.1    Nguyen, T.2    West, E.J.3
  • 54
    • 70350717086 scopus 로고    scopus 로고
    • Stroke prevention by cilostazol in patients with atherothrombosis: Meta-analysis of placebo-controlled randomized trials
    • Uchiyama S, Demaerschalk BM, Goto S, Shinohara Y, Gotoh F, Stone WM, et al. Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis 2009; 18:482-490.
    • (2009) J Stroke Cerebrovasc Dis , vol.18 , pp. 482-490
    • Uchiyama, S.1    Demaerschalk, B.M.2    Goto, S.3    Shinohara, Y.4    Gotoh, F.5    Stone, W.M.6
  • 56
    • 67649109740 scopus 로고    scopus 로고
    • Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation
    • Park KH, Jeong MH, Lee MG, Ko JS, Lee SE, Kang WY, et al. Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation. Korean Circ J 2009; 39:190-197.
    • (2009) Korean Circ J , vol.39 , pp. 190-197
    • Park, K.H.1    Jeong, M.H.2    Lee, M.G.3    Ko, J.S.4    Lee, S.E.5    Kang, W.Y.6
  • 57
    • 0017623853 scopus 로고
    • Cardiac pacing and pacemaker. I: Indications for pacing bradyarrhythmias
    • Furman S. Cardiac pacing and pacemaker. I: Indications for pacing bradyarrhythmias. Am Heart J 1977; 93:523-530.
    • (1977) Am Heart J , vol.93 , pp. 523-530
    • Furman, S.1
  • 58
    • 12344277382 scopus 로고    scopus 로고
    • Role of permanent pacing to prevent atrial fibrillation: Science Advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes research interdisciplinary Working Group, in collaboration with the Heart Rhythm Society
    • DOI 10.1161/01.CIR.0000151800.84945.47
    • Knight BP, Gersh BJ, Carlson MD, Friedman PA, McNamara RL, Strickberger SA, et al. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 2005; 111:240-243. (Pubitemid 40139737)
    • (2005) Circulation , vol.111 , Issue.2 , pp. 240-243
    • Knight, B.P.1    Gersh, B.J.2    Carlson, M.D.3    Friedman, P.A.4    McNamara, R.L.5    Strickberger, S.A.6    Tse, H.F.7    Waldo, A.L.8
  • 60
    • 0021260740 scopus 로고
    • Amrinone: Acute electrophysiologic and hemodynamic effects in patients with congestive heart failure
    • Naccarelli GV, Gray EL, Dougherty AH, Hanna JE, Goldstein RA. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure. Am J Cardiol 1984; 54:600-604. (Pubitemid 14073252)
    • (1984) American Journal of Cardiology , vol.54 , Issue.6 , pp. 600-604
    • Naccarelli, G.V.1    Gray, E.L.2    Dougherty, A.H.3
  • 61
    • 0023780277 scopus 로고
    • Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart
    • Belardinelli L, Giles WR, West A. Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J Physiol 1988; 405:615-633.
    • (1988) J Physiol , vol.405 , pp. 615-633
    • Belardinelli, L.1    Giles, W.R.2    West, A.3
  • 62
    • 0035997540 scopus 로고    scopus 로고
    • Potentiation of the negative dromotropic effect of adenosine by rapid heart rates: Possible ionic mechanism
    • DOI 10.1007/s00395-002-0354-y
    • Martynyuk AE, Zima A, Seubert CN, Morey TE, Belardinelli L, Dennis DM. Potentiation of the negative dromotropic effect of adenosine by rapid heart rates: possible ionic mechanism. Basic Res Cardiol 2002; 97:295-304. (Pubitemid 34808776)
    • (2002) Basic Research in Cardiology , vol.97 , Issue.4 , pp. 295-304
    • Martynyuk, A.E.1    Zima, A.2    Seubert, C.N.3    Morey, T.E.4    Belardinelli, L.5    Dennis, D.M.6
  • 63
    • 42149139071 scopus 로고    scopus 로고
    • Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction
    • DOI 10.1139/Y08-005
    • Sanganalmath SK, Barta J, Takeda N, Kumamoto H, Dhalla NS. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction. Can J Physiol Pharmacol 2008; 86:180-189. (Pubitemid 351536449)
    • (2008) Canadian Journal of Physiology and Pharmacology , vol.86 , Issue.4 , pp. 180-189
    • Sanganalmath, S.K.1    Barta, J.2    Takeda, N.3    Kumamoto, H.4    Dhalla, N.S.5
  • 64
    • 77956884231 scopus 로고    scopus 로고
    • Cilostazol for prevention of secondary stroke (CSPS 2): An aspirin-controlled, double-blind, randomised non-inferiority trial
    • Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 2010; 9:959-968.
    • (2010) Lancet Neurol , vol.9 , pp. 959-968
    • Shinohara, Y.1    Katayama, Y.2    Uchiyama, S.3    Yamaguchi, T.4    Handa, S.5    Matsuoka, K.6
  • 65
    • 55449088781 scopus 로고    scopus 로고
    • Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality
    • Barta J, Sanganalmath SK, Kumamoto H, Takeda N, Edes I, Dhalla NS. Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality. Cardiovasc Toxicol 2008; 8:127-135.
    • (2008) Cardiovasc Toxicol , vol.8 , pp. 127-135
    • Barta, J.1    Sanganalmath, S.K.2    Kumamoto, H.3    Takeda, N.4    Edes, I.5    Dhalla, N.S.6
  • 66
    • 0033537470 scopus 로고    scopus 로고
    • 'Brugada' syndrome: Clinical data and suggested pathophysiological mechanism
    • Alings M, Wilde A. 'Brugada' syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999; 99:666-673.
    • (1999) Circulation , vol.99 , pp. 666-673
    • Alings, M.1    Wilde, A.2
  • 67
    • 31444441326 scopus 로고    scopus 로고
    • The Brugada syndrome: An update
    • Shimizu W. The Brugada syndrome: an update. Intern Med 2005; 44:1224-1231.
    • (2005) Intern Med , vol.44 , pp. 1224-1231
    • Shimizu, W.1
  • 70
    • 3843151619 scopus 로고    scopus 로고
    • Brugada and long QT-3 syndromes: Two phenotypes of the sodium channel disease
    • DOI 10.1111/j.1542-474X.2004.93533.x
    • Khan IA, Nair CK. Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease. Ann Noninvasive Electrocardiol 2004; 9:280-289. (Pubitemid 39044081)
    • (2004) Annals of Noninvasive Electrocardiology , vol.9 , Issue.3 , pp. 280-289
    • Khan, I.A.1    Nair, C.K.2
  • 71
    • 33749070756 scopus 로고    scopus 로고
    • Brugada syndrome: Overview
    • Antzelevitch C, Brugada P, Brugada J, Brugada R, editors. Oxford: Blackwell-Futula
    • Antzelevitch C. Brugada syndrome: overview. In: Antzelevitch C, Brugada P, Brugada J, Brugada R, editors. The Brugada syndrome: from bench to bedside. Oxford: Blackwell-Futula; 2005. pp. 1-22.
    • (2005) The Brugada Syndrome: From Bench to Bedside , pp. 1-22
    • Antzelevitch, C.1
  • 72
    • 33750059805 scopus 로고    scopus 로고
    • Cellular mechanisms underlying the Brugada syndrome
    • Antzelevitch C, Brugada P, Brugada J, Brugada R, editors. Oxford: Blackwell-Futura
    • Antzelevitch CP, Fish JMD, Di Diego JMM. Cellular mechanisms underlying the Brugada syndrome. In: Antzelevitch C, Brugada P, Brugada J, Brugada R, editors. The Brugada syndrome: from bench to bedside. Oxford: Blackwell-Futura; 2005. pp. 52-77.
    • (2005) The Brugada Syndrome: From Bench to Bedside , pp. 52-77
    • Antzelevitch, C.P.1    Fish, J.M.D.2    Di Diego, J.M.M.3
  • 74
    • 0141986515 scopus 로고    scopus 로고
    • Heart rate variability in patients with Brugada syndrome in Thailand
    • DOI 10.1016/j.ehj.2003.06.005
    • Krittayaphong R, Veerakul G, Nademanee K, Kangkagate C. Heart rate variability in patients with Brugada syndrome in Thailand. Eur Heart J 2003; 24:1771-1778. (Pubitemid 37236867)
    • (2003) European Heart Journal , vol.24 , Issue.19 , pp. 1771-1778
    • Krittayaphong, R.1    Veerakul, G.2    Nademanee, K.3    Kangkagate, C.4
  • 75
    • 10744229848 scopus 로고    scopus 로고
    • Decreased nocturnal standard deviation of averaged NN intervals. An independent marker to identify patients at risk in the Brugada syndrome
    • Hermida JS, Leenhardt A, Cauchemez B, Denjoy I, Jarry G, Mizon F, et al. Decreased nocturnal standard deviation of averaged NN intervals. An independent marker to identify patients at risk in the Brugada syndrome. Eur Heart J 2003; 24:2061-2069.
    • (2003) Eur Heart J , vol.24 , pp. 2061-2069
    • Hermida, J.S.1    Leenhardt, A.2    Cauchemez, B.3    Denjoy, I.4    Jarry, G.5    Mizon, F.6
  • 76
    • 33644786312 scopus 로고    scopus 로고
    • Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome
    • DOI 10.1111/j.1540-8167.2005.00290.x
    • Abud A, Bagattin D, Goyeneche R, Becker C. Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2006; 17:210-212. (Pubitemid 43344873)
    • (2006) Journal of Cardiovascular Electrophysiology , vol.17 , Issue.2 , pp. 210-212
    • Abud, A.1    Bagattin, D.2    Goyeneche, R.3    Becker, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.